| RS6110038 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
— |
| RS61126080 |
KRT5
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex with migratory circinate erythema, Epidermolysis bullosa simplex |
| RS61130669 |
DES
|
Health Risk |
Conflicting classifications of pathogenicity |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS61145796 |
KRT6A
|
Health Risk |
Pathogenic |
Pachyonychia congenita 3, Pachyonychia congenita 3 |
| RS61157095 |
KRT9
|
Health Risk |
Pathogenic |
Epidermolytic palmoplantar keratoderma, 1 |
| RS61167390 |
KRT12
|
Health Risk |
Likely pathogenic |
— |
| RS6118004 |
HAO1
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS61195471 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1A, Primary dilated cardiomyopathy |
| RS6121 |
PROS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia due to protein S deficiency, autosomal dominant |
| RS61214927 |
LMNA
|
Health Risk |
Pathogenic |
Familial partial lipodystrophy, Dunnigan type |
| RS61218140 |
EVC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS61218439 |
KRT1
|
Health Risk |
Pathogenic |
Ichthyosis, annular epidermolytic |
| RS6122 |
PROS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia due to protein S deficiency, autosomal recessive |
| RS61221088 |
KRT14
|
Health Risk |
Pathogenic |
— |
| RS61232800 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS61235244 |
LMNA
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS61263401 |
KRT14
|
Health Risk |
Pathogenic/Likely pathogenic |
Epidermolysis bullosa simplex, Koebner type |
| RS61282106 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial partial lipodystrophy, Dunnigan type |
| RS61294616 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperaldosteronism, familial |
| RS61295588 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1A, Charcot-Marie-Tooth disease type 2 |
| RS61297109 |
KRT5
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 1C, localized |
| RS61323727 |
ABCB7
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCB7-related disorder, Uveal melanoma |
| RS61326562 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS61348424 |
KRT5
|
Health Risk |
Pathogenic |
Dowling-Degos disease 1, Dowling-Degos disease 1 |
| RS61348633 |
KRT5
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 2A, generalized severe |
| RS61368398 |
DES
|
Health Risk |
Conflicting classifications of pathogenicity |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS61371557 |
KRT14
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa simplex, Koebner type |
| RS61372944 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS6138 |
TBXAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
TBXAS1-related disorder, TBXAS1-related disorder |
| RS613985 |
HBB
|
Health Risk |
Pathogenic |
Beta-thalassemia HBB/LCRB, Beta-thalassemia HBB/LCRB |
| RS6140463 |
HAO1
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS61434181 |
KRT10
|
Health Risk |
Pathogenic |
Epidermolytic hyperkeratosis 1, Epidermolytic hyperkeratosis 1 |
| RS61444459 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary dilated cardiomyopathy, Charcot-Marie-Tooth disease type 2 |
| RS61460100 |
KRT10
|
Health Risk |
Pathogenic |
— |
| RS61462443 |
KDM6B
|
Health Risk |
Conflicting classifications of pathogenicity |
KDM6B-related disorder, KDM6B-related disorder |
| RS61469168 |
C6
|
Health Risk |
Pathogenic |
Complement component 6 deficiency, Immunodeficiency due to a late component of complement deficiency |
| RS6147 |
VLDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebellar ataxia, intellectual disability |
| RS61491953 |
NEFL
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 2E |
| RS61494991 |
PHKB
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS61495052 |
KRT5
|
Health Risk |
Pathogenic |
— |
| RS61495246 |
CYP2R1
|
Health Risk |
Pathogenic/Likely pathogenic |
Vitamin D hydroxylation-deficient rickets, type 1B |
| RS61504484 |
CLN5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis |
| RS6151411 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS6151414 |
ARSA
|
Health Risk |
Conflicting classifications of pathogenicity |
Metachromatic leukodystrophy, ARSA-related disorder |
| RS61514191 |
EVC
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS6151426 |
ARSA
|
Health Risk |
Conflicting classifications of pathogenicity |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS6151427 |
ARSA
|
Health Risk |
Conflicting classifications of pathogenicity |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS6151428 |
ARSA
|
Health Risk |
Conflicting classifications of pathogenicity |
Metachromatic leukodystrophy, Malignant lymphoma |
| RS61521463 |
CCDC15
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61536893 |
KRT14
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa simplex 1C, localized |
| RS6154 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS61548169 |
SACS
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS61556467 |
NEFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, NEFH-related disorder |
| RS61578124 |
LMNA
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS6161 |
CYP11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital adrenal insufficiency with 46, XY sex reversal OR 46 |
| RS61616632 |
KRT1
|
Health Risk |
Pathogenic |
Epidermolytic ichthyosis, Epidermolytic ichthyosis |
| RS61618583 |
SCN8A
|
Health Risk |
Pathogenic |
— |
| RS61620549 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Inborn genetic diseases |
| RS61622928 |
DPYD
|
Health Risk |
Conflicting classifications of pathogenicity |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS61622935 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS61636783 |
EFHC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS61661343 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1A, Charcot-Marie-Tooth disease type 2 |
| RS61664582 |
KRT14
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex, Koebner type |
| RS6167 |
FSHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian hyperstimulation syndrome, Ovarian dysgenesis 1 |
| RS61672878 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy, Emery-Dreifuss muscular dystrophy 2 |
| RS61686936 |
CCDC40
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 15 |
| RS61688134 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Myocardial infarction |
| RS6170 |
FSHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 24 without anosmia, FSHB-related disorder |
| RS61726452 |
KRT2
|
Health Risk |
Likely pathogenic |
Ichthyosis bullosa of Siemens, Ichthyosis bullosa of Siemens |
| RS61726467 |
DES
|
Health Risk |
Pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS61726470 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS61726471 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS61726474 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS61726475 |
LMNA
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1A, Hutchinson-Gilford syndrome |
| RS61729175 |
HPS4
|
Health Risk |
Conflicting classifications of pathogenicity |
HPS4-related disorder, Inborn genetic diseases |
| RS61729285 |
CAVIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Congenital generalized lipodystrophy type 4 |
| RS61729341 |
ZNF750
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61729385 |
DBH
|
Health Risk |
Conflicting classifications of pathogenicity |
Orthostatic hypotension 1, Orthostatic hypotension 1 |
| RS61729440 |
DCX
|
Health Risk |
Pathogenic |
Ectopic tissue, Lissencephaly type 1 due to doublecortin gene mutation |
| RS61729604 |
AGXT
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hyperoxaluria, type I |
| RS61729699 |
DNHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Spermatogenic failure 65, Spermatogenic failure 65 |
| RS61729706 |
CEACAM16
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS61729766 |
ITGA11
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61729789 |
SCNN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Liddle syndrome 1, Pseudohypoaldosteronism |
| RS61729805 |
LIPG
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61729833 |
MYO3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 30, Autosomal recessive nonsyndromic hearing loss 30 |
| RS61729841 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS61729932 |
BRAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal-onset encephalopathy with rigidity and seizures, Intellectual disability |
| RS61729954 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS61730004 |
USP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Cholestasis, progressive familial intrahepatic |
| RS61730005 |
USP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Cholestasis, progressive familial intrahepatic |
| RS61730049 |
CMYA5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61730051 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS61730054 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, 8 conditions |
| RS61730086 |
PAX8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypothyroidism, congenital |
| RS61730102 |
ANKRD26
|
Health Risk |
Conflicting classifications of pathogenicity |
ANKRD26-related disorder, Inborn genetic diseases |
| RS61730147 |
AHR
|
Health Risk |
Pathogenic |
— |
| RS61730252 |
FAM20C
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, FAM20C-related disorder |
| RS61730262 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fibrochondrogenesis 2, Otospondylomegaepiphyseal dysplasia |
| RS61730307 |
DSG1
|
Health Risk |
Conflicting classifications of pathogenicity |
DSG1-related disorder, Inborn genetic diseases |